CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
358,567
Share change
-22,946,641
Total reported value
$1,026,000
Price per share
$2.86
Number of holders
2
Value change
-$25,213,191
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q2 2022

As of 30 Jun 2022, CASI PHARMACEUTICALS INC - COM (CASI) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 358,567 shares. The largest 2 holders included Wellington Shields Capital Management, LLC and Wellington Shields & Co., LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.